The abnormal and variable increase in levels of free sphingoid bases recently described in fibroblasts from Niemann-Pick C patients allowed us to investigate the modulation of protein kinase C in i o by endogenous sphingosine. The specific binding of [20-$H]phorbol 12,13-dibutyrate to the regulatory domain of membrane-bound protein kinase C was significantly decreased in fibroblasts from patients compared with controls. A pronounced difference between the two groups (P 0.0001) was demonstrated in low-density lipoprotein-supplemented medium, i.e. under conditions known to disclose abnormal mobilization of unesterified cholesterol in Niemann-Pick C fibroblasts. Furthermore the degree of impairment of [$H]phorbol 12,13-
INTRODUCTION
Sphingosine has gained attention as a bioactive compound since it was shown to induce a potent and reversible inhibition of protein kinase C (PKC) after addition to cell cultures [1, 2] and to affect other signal transduction pathways (reviewed in [3] ). Furthermore the N-acyl (i.e. ceramide) and 1-phosphate derivatives of sphingosine are highly bioactive and are emerging as intracellular mediators. Amounts of free sphingoid bases in tissues and cultured cells are generally low and constant [4, 5] . We have previously described a 20-40-fold elevation of sphingosine and sphinganine levels in tissues from patients affected by the genetic disease Niemann-Pick C (NPC) [6] and its Balb\c murine model [7] . A significant increase in free sphingoid bases also occurred in NPC fibroblasts, disproportionate to the minimal degree of lipid storage, and varying between cell lines from near normal up to a 10-fold increase. Furthermore addition of 10 µM sphinganine to normal fibroblast cultures has been shown to induce a biochemical NPC phenotype [8] characterized by abnormalities in cellular trafficking of unesterified cholesterol associated with its lysosomal accumulation (reviewed in [9] ). These two observations suggest that sphingoid bases might participate in the physiopathology of the disease because PKC has been shown to be involved in the activation of cholesterol transport [10, 11] . Moreover, NPC provides the first tool for studying the modulation of PKC activity by endogenous sphingosine. Because sphingosine is postulated to inhibit PKC by interaction at the regulatory domain with the phorbol ester binding sites or with other lipidic cofactors [2] , the binding of [20- $H]phorbol 12,13-dibutyrate ([$H]PDB) to membrane-bound PKC was studied in living fibroblasts from NPC patients in relation to cholesterol overload and sphingosine levels.
Abbreviations used : LDL, low-density lipoprotein ; LPDS, lipoprotein-deficient serum ; NPC, Niemann-Pick C disease ; [ 3 H]PDB, H]phorbol 12,13-dibutyrate ; PKC, protein kinase C. 1 To whom correspondence should be addressed.
dibutyrate binding was highly correlated (r l 0.95) with the sphingosine levels measured in fibroblasts from those patients. Scatchard analysis of the binding data indicated that NiemannPick C and control fibroblasts contained almost the same number of binding sites per cell. A 8-34-fold increase in K d was measured in Niemann-Pick C fibroblasts with at least a 5-fold increase in sphingosine levels. Removal, by cell fractionation, of membranebound protein kinase C from the bulk of sphingosine induced a normalization of K d values. The overall results suggest that protein kinase C inhibition is directly related to sphingosine accumulation. 
MATERIALS AND METHODS

Chemical and biological reagents
Cell culture conditions
Skin fibroblasts from 12 NPC patients belonging to the major group of complementation and showing severe alterations in intracellular LDL-cholesterol processing [9] were used in this study. Ten control cell lines were obtained from healthy volunteers and children with other lysosomal storage diseases (Krabbe and Sandhoff diseases). Cells grown by standard procedures [13] were seeded either in 6-well culture plates (Nunc) (40 000 cells per well) for [$H]PDB binding studies or in 75 cm# flasks for sphingosine analysis and for fractionation procedures.
In most experiments they were grown either for 3 days in a cholesterol-deprived medium [McCoy's 5A medium supplemented with 10 % (v\v) human LPDS] followed by 24 h in an LDL-supplemented medium (10 % LPDS\50 µg\ml LDL) or 4 days in an LPDS medium.
Intoxication with sphinganine
Fibroblasts were preincubated for 20 min at 37 mC with increasing concentrations of sphinganine for dose-effect studies. Sphing-anine addition was maintained in the medium during the binding procedure. 
Intoxication with fumonisin
Binding of [ 3 H]PDB to membrane fractions
Preparation of membrane fractions
Cells from two 75 cm# flasks were collected by scraping, pooled and pelleted by low-speed centrifugation. They were then disrupted in a Potter-Elvehjem homogenizer in 1 ml of ice-cold buffer containing 0.25 M sucrose, 50 mM Tris\HCl, pH 7.4, and 10 µg\ml leupeptin. The homogenate was centrifuged at 10 000 g for 15 min at 4 mC in a Beckman TL100 ultracentrifuge. The pellet was discarded and the supernatant centrifuged at 100 000 g for 75 min. The 100 000 g pellet was resuspended in 0.2 ml of 50 mM Tris\HCl buffer and stored at k80 mC until needed for the binding assay.
Binding assay
The soluble phorbol ester receptor assay was done as described by Driedger and Blumberg [15] , with the after modifications : the sample was reduced to 0.3-0.4 µg of the membrane-bound protein preparation, the specific radioactivity of [$H]PDB used was 20-fold higher, 50 mM Tris\HCl buffer was supplemented with 0.5 % BSA, and incubations were performed at 37 mC instead of 39 mC. Scatchard experiments proceeded with increasing concentrations of [$H]PDB (7.25 to 200 nM) and the analysis of results by the Scatchard method was done as described above.
Content of free sphingoid bases in fibroblasts
Quantification of sphingosine and sphinganine was performed on a total lipid extract by HPLC [6] . Results are expressed as pmol\mg of protein, measured by the Hartree method [16] with serum albumin as the standard.
RESULTS
General characteristics of [ 3 H]PDB binding to living skin fibroblasts
The whole-cell phorbol receptor assay was adapted to fibroblast cultures from that described by Hannun et al. [1] for suspended cells ; special conditions of washing and cell collection were defined. Figure 1 shows the kinetics of [$H]PDB binding obtained for NPC and control fibroblasts as a function of culture conditions and temperature. The two conditions of culture classically used to discriminate NPC fibroblasts from normal ones
Figure 1 Effect of incubation time on [ 3 H]PDB binding to living fibroblasts as a function of conditions of culture (A) and temperature (B)
(A) Fibroblasts from controls (#,$) or NPC patients (=,>) were grown for either 4 days in a cholesterol-deprived medium (LPDS medium) (#,=) or 3 days in LPDS medium followed by 24 h of LDL (50 µg/ml) addition ($,>) (see the Materials and methods section). 
H]PDB binding to control fibroblasts
Sphinganine was added at the indicated concentration to normal fibroblasts grown for either 4 days in a cholesterol-deprived medium (#) or 3 days in a cholesterol-deprived medium followed by 24 h of LDL ($). After incubation for 20 min at 37 mC with sphinganine, 10 nM were studied as shown in Figure 1 (A). Cells were grown for 3 days in a lipoprotein-deficient medium to express the LDL receptors and were thereafter either challenged in an LDLsupplemented medium for 24 h (classical conditions for displaying cholesterol sequestration in NPC fibroblasts) (LDL conditions in Figure 1 ) or maintained for 24 h in a cholesteroldeprived medium, run as negative control (LPDS in Figure 1 
H]PDB binding to living fibroblasts from NPC patients and control subjects
Fibroblasts from 12 NPC patients and seven control subjects were grown for either 3 days in LPDS medium followed by 24 h of LDL (50 µg/ml) (LDL) or 4 days in a cholesterol-deprived medium (LPDS) and then subjected to 
Correlation of [ 3 H]PDB binding with sphingosine levels in NPC fibroblasts
To investigate the relationship between decreased [$H]PDB binding and sphingosine levels in NPC fibroblasts, quantification of sphingosine by HPLC was run in parallel with binding studies. Individual results obtained in eight NPC cell lines are presented in Figure 4 . For each of the two parameters, areas delimited by broken lines define the range of values obtained in four control cell lines. The mean sphingosine levels were 460p235 pmol\mg of protein (n l 8) in NPC fibroblasts and 80p20 pmol\mg of protein (n l 4) in controls. As shown in the inset to Figure 4 , the graded impairment of [$H]PDB binding to fibroblasts from the eight NPC patients studied was highly correlated (r l 0.95) with their sphingosine levels. This observation strongly suggests a direct relation between inhibition of [$H]PDB binding and sphingosine accumulation, and thus a potential modulation of PKC activity by endogenous sphingosine.
Scatchard analyses
The previous results imply that sphingosine interacts with the surface-bound PKC, probably by interfering with its regulatory domain. To test this hypothesis, Scatchard analyses were made on data from binding studies, performed at 4 mC on fibroblasts from five of the previous NPC patients (2, 3, 5, 6 and 8), three healthy controls and two pathological controls (Krabbe disease),
Figure 4 Correlation between [ 3 H]PDB binding and sphingosine levels in NPC fibroblasts
Fibroblasts from eight NPC patients were cultured for 3 days in LPDS medium and then for 1 day in LDL-enriched medium ; they were then analysed for A pharmacological modulation of intracellular sphingoid bases content was undertaken to strengthen our findings. Control fibroblasts were incubated for 48 h with 20 µM fumonisin B1, an inhibitor of ceramide synthase [18] , to induce the accumulation of sphingoid bases. A marked increase in sphinganine levels Because the addition of 10 µM sphinganine to normal cells can induce an NPC phenotype [8] we investigated whether this would also occur after fumonisin B1 treatment. There was no evidence of vesicular accumulation of unesterified cholesterol after 24 h of LDL uptake, whereas a marked decrease in cholesteryl ester formation after 4.5 h of LDL addition was observed.
Reversibility of inhibition of [ 3 H]PDB binding in NPC fibroblasts
To corroborate our results and to evaluate the reversibility of the inhibition of [$H]PDB binding in NPC fibroblasts, the removal of membrane-bound PKC from the bulk of sphingosine was attempted. Low-speed centrifugation (10 000 g) was first applied to fibroblasts of NPC patients 5 and 8 with high sphingosine levels and K d values, as well as those of one healthy control. The pellet obtained from NPC fibroblasts contained 81 % of total cellular sphingosine ; the supernatant was subjected to a 100 000 g centrifugation to obtain a plasma membrane fraction (6 % sphingosine) and a cytosolic fraction (13 % sphingosine).
[$H]PDB binding studies were performed on the membranebound fraction (100 000 g pellet) of NPC and control fibroblasts by the method of Driedger and Blumberg [15] ; K d values were compared with those previously obtained for intact cells ( [24, 25] have shown that LDL induces a rapid but transient cytosol-to-membrane translocation of PKC in human vascular smooth-muscle cells or skin fibroblasts. However, these findings concerned the early response to LDL uptake, whereas the present study reports the effects of a long-term stimulation. Decreased binding of PKC to the membrane observed in NPC fibroblasts in relation to unesterified cholesterol overload might reflect a downregulation process counteracting further putative LDL-mediated PKC activation. The catalytic activity of PKC has been shown to be decreased by 70 % in mucolipidosis 4 and to a lesser extent in Niemann-Pick A cells [19] or, as recently published, to be stimulated in fibroblasts from Zellweger patients [20] . We did not find any significant variation in either [$H]PDB binding or sphingosine levels in fibroblast cultures from patients with Krabbe and Sandhoff diseases.
Our study corroborates the hypothesis first raised by Hannun and Bell [26] and recently revived by Boneh [27] , who speculated that a modulation of PKC activity, subsequent to the accumulation of naturally occurring PKC modulators, might occur in sphingolipidoses and participate in the physiopathology of the diseases through the derangement of various cellular functions. An alteration of signal transduction in NPC fibroblasts is in good agreement with the data of Yamamoto et al. [28] , who found that the early response of NPC fibroblasts to LDL uptake by changes in intracellular Ca# + is significantly decreased compared with control cells.
There was no evidence for a direct relation between the variable decrease in [$H]PDB binding (or increase in sphingosine levels) and the biochemical or clinical phenotypes of NPC patients. The selected cell lines showed a uniform severe block in intracellular sterol trafficking and were obtained from patients spanning the entire spectrum of clinical phenotypes (Figure 4 ). Sphingosine accumulation might be related to several perturbations of the sphingolipid metabolism (C. Rodriguez-Lafrasse, J. Ledrinova and M. T. Vanier, unpublished work). The pharmacological modulation of intracellular sphinganine content in control cells by fumonisin B1 was also associated with a 40 % decrease in [$H]PDB binding. We have observed that fumonisin B1 strongly inhibits cholesterol esterification but cannot induce a lysosomal sequestration of LDL-cholesterol, at variance with the exogenous addition of 10 µM sphinganine [10] , suggesting that the drug blocks LDL uptake or transport to the lysosome. Therefore the absence of K d modification might be explained by differences in cholesterol homeostasis of the cells.
Our Scatchard analyses, combined with the previous interpretation of experiments in itro [2] , lead us to propose the following mechanism for [$H]PDB-binding inhibition in NPC fibroblasts. At low concentration, considering the absence of K d modification, endogenous sphingosine could act either by means of chemical This study first documents the inhibition of [$H]PDB binding by endogenous sphingosine and gives a potentially relevant insight into NPC, because PKC has been widely involved in the activation of cholesterol transport by sterol carrier protein 2 [10] and intermediate filaments [29] and of HDL-mediated cholesterol efflux [11] .
